Skip to Content

Published on April 08, 2015

Presentation by Dr. Sidhu gains international attention

Dr. SidhuA hematopathology case study presented by Jagmohan Sidhu, MD, at a recent conference in Istanbul, Turkey, received high praise from hematopathologists in attendance from around the world. The European Association of Haematopathology and Society for Hematopathology (American and Canadian) held its 17th combined international meeting in Istanbul. In a workshop on lymphoma, or cancer of the lymphatic system, 26 cases - including one from UHS - were selected for podium presentations out of approximately 200 submitted from three continents. The case study offered by Dr. Sidhu, medical director of Pathology and Laboratory Services at UHS Hospitals, was one of only two from non-university medical centers. The others were from institutions such as the Mayo Clinic, Memorial Sloan Kettering and the National Institutes of Health, as well as from leading hospitals in Great Britain and other European countries.

Because Dr. Sidhu has made presentations at the conference in past years, his name and that of UHS in Binghamton, N.Y., are well-known to the doctors in attendance from around the world. "I have been the only presenter from a non-university medical center several times in the past at this top-quality international conference," Dr. Sidhu told UHS News. "I am very pleased that UHS is able to be in the spotlight internationally because of the great work done year after year by our Laboratory Services program right here in Greater Binghamton." At the most recent conference, there were 690 attendees. Dr. Sidhu described for UHS News the hematopathological study he presented:

"It was a unique case, a rare variant of follicular lymphoma. We performed several studies ourselves and got combined comparative genomic hybridization and single nucleotide polymorphism (CGH+SNP) microarrays molecular studies done on this case at Dr. Richard Burack’s lab at the University of Rochester Medical Center. "With help from Dr. Burack, I interpreted these studies for the gains and losses of genes in this lymphoma and came up with an interesting conclusion about the possible nature of this variant of follicular lymphoma.

"I concluded that this case is most likely an intrafollicularly transformed follicular lymphoma, which means it is a high-grade lymphoma (others have called it a blastoid follicular lymphoma, but there is no universal agreement on the true nature of this variant - whether it is low- or high-grade). This conclusion was liked by many attendees including Dr. Randy Gascoyne (from the University of British Columbia), one of the well-known experts in this entity, who remarked that it is possible that I could be describing a new entity.

"Dr. Marcus Kremer, a very well-known lymphoma expert from Germany, met me after the presentation and congratulated me on my presentation. He has published the most recent paper on lymphocyte trafficking in follicular lymphoma, and I had used his paper, with the help of PowerPoint animation, to describe lymphocyte trafficking. Dr. Kremer said, 'This was a very brilliant way of describing lymphocyte trafficking in follicular lymphoma.'"